Our Perspectives are at the forefront of complex or emerging IP challenges, keeping you one step ahead.
The Issues we focus on target your recurring and strategic IP challenges, through cross-functional support.
We provide sector-specific support in a number of business areas historically linked to Regimbeau.
Regardless of the asset to be protected or enhanced, we have the right dedicated team to assist you.
For each type of company, Regimbeau provides tailor-made support, in line with its realities.
Our Perspectives are at the forefront of complex or emerging IP challenges, keeping you one step ahead.
The Issues we focus on target your recurring and strategic IP challenges, through cross-functional support.
We provide sector-specific support in a number of business areas historically linked to Regimbeau.
Regardless of the asset to be protected or enhanced, we have the right dedicated team to assist you.
For each type of company, Regimbeau provides tailor-made support, in line with its realities.
Raphaëlle Gillet and Nicolas Bouquin will discuss the latest decisions regarding antibody patents and in particular the Amgen PCSK9 case at AIS 2021, on June 23rd 2021 at 2PM.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
More information about our Cookie Policy
